Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to trial content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedThe website shows a revision update from v3.4.0 to v3.4.1, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThese are minor UI/metadata updates: a glossary toggle was added, the QC date label was updated to 'Last Update Submitted that Met QC Criteria', and the page version noted as 'Revision: v3.4.0' while older wording and the prior version label were removed.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. This is a minor site maintenance update and does not change study content or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedA new Locations section is added with state entries (CA, HI, LA, MD, MA, MO, NY, OH, TX, WA). The page revision is updated to v3.3.3 and previous state-specific location blocks are removed.SummaryDifference0.9%

- Check91 days agoChange DetectedThe page now shows a new Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.